Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Vincent Luong Vincent Luong @VincentLuong.200361
Feb 5, 2021 $87.95 +96.32% $44.80 X 3.68% 1
JS JS Pro
Feb 4, 2021 $80.22 +26.47% $63.43 X 73.53% 1
JS JS Pro
Aug 20, 2020 $3.44 +1.78% $3.38 X 98.22% 1
iHustle84 iHustle84 Pro
Aug 20, 2020 $3.60 +6.51% $3.38 X 93.49% 0
Aug 20, 2020 $3.61 +6.80% $3.38 X 93.20% 0
Jan 9, 2020 Bullish $7.93 X 1
2poJeff 2poJeff Pro
Jan 9, 2020 $7.92 -0.13% $7.93 X 99.87% 6
Randy Bean Randy Bean @RandyBean.131945
Jan 9, 2020 Bearish $7.93 X 0
Janardan Burns Janardan Burns @JanardanBurns.131075
Dec 24, 2019 $4.00 -12.09% $4.55 X 87.91% 1
Dec 23, 2019 Bearish $3.59 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE